Aquaporin-4 deficiency diminishes the differential degeneration of midbrain dopaminergic neurons in experimental Parkinson's disease. (12th February 2016)

• Record Type: Journal Article
• Authors: Zhang, Ji; Yang, Beibei; Sun, Hongbin; Zhou, Yan; Liu, Mengdi; Ding, Jianhua; Fang, Feng; Fan, Yi; Hu, Gang
• Is Part Of: Neuroscience letters. Volume 614(2016)
• Page Start: 7
• Page End: 15
• Publication Date: 2016-02-12
• Subjects: Aquaporin 4 -- Parkinson's disease -- Neurodegeneration -- Dopamine -- Astrocyte; Neurology -- Periodicals; Neurology -- Periodicals; Research -- Periodicals; Neurologie -- Périodiques; Neuroanatomie -- Périodiques; Neuropharmacologie -- Périodiques; Neurophysiologie -- Périodiques; Neurology; Periodicals; Electronic journals; 617.48
• DOI: 10.1016/j.neulet.2015.12.057
• Languages: English
• ISSNs: 0304-3940

Abstract

Highlights: AQP4 deficiency diminished the differential degeneration of midbrain dopaminergic neurons in Parkinson's disease. AQP4 deficiency exacerbated gliosis not only in the SN and but also in the VTA under basal and MPTP-induced situations. AQP4 deficiency disrupted the balance of the pro-inflammatory cytokine/neurotrophin in midbrain. Abstract: Parkinson's disease (PD) is primarily due to the progressive, selective and irreversible loss of dopaminergic (DA) neurons in the substantia nigra (SN). Interestingly, DA neurons in the ventral and lateral SN are much more susceptible than adjacent dopamine neurons in the ventral tegmental area (VTA) not only in human PD but in many PD model systems. However, the molecular causes of regional vulnerability in PD remain unknown. In our previous studies, we established acute PD animal models by administration of MPTP (1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine), and found that AQP4 knockout mice were significantly more prone to MPTP-induced neurotoxicity. Here, we further observe that AQP4 deficiency resulted in the same susceptible to MPTP between SN DA neuron and VTA neurons both in acute and chronic PD model. Moreover, we show that AQP4 deficiency increased the numbers of reactive astrocytes and microglias not only in the SN and but also in the VTA under basal and MPTP-induced situations. Meanwhile, AQP4 deficiency disrupted the balance of the pro-inflammatory cytokine/neurotrophin in midbrain. Taken together, these results demonstrate that glial AQP4 is involved in the susceptibility differences of DA neurons between SN and VTA, although the precise mechanism of AQP4 remains to be explored. Moreover, these findings also suggest that these susceptibility differences are not only due to intrinsic neuronal factors, but also attribute to differences in astrocytes of these regions.